Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Karyopharm Therapeutics Inc
University of Nebraska
Adela, Inc
Mayo Clinic
University of Alabama at Birmingham
Universidade Federal de Pernambuco
Incyte Corporation
Mayo Clinic
CureOne
Wake Forest University Health Sciences
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc